Dudler; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dudler; Thomas.The latest application filed is for "biomarker for assessing the risk of developing acute covid-19 and post-acute covid-19".

Company Profile

19.19.43

Dudler; Thomas - Seattle WA
Dudler; Thomas - Bellevue WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biomarker For Assessing The Risk Of Developing Acute Covid-19 And Post-acute Covid-19 App 20220308056 - Demopulos; Gregory A. ; et al.	2022-09-29
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders App 20220259325 - Schwaeble; Hans-Wilhelm ; et al.	2022-08-18
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20220089781 - Demopulos; Gregory A. ; et al.	2022-03-24
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20220002439 - Demopulos; Gregory A. ; et al.	2022-01-06
Methods For Inhibiting Fibrosis In A Subject In Need Thereof App 20210355236 - Brunskill; Nigel John ; et al.	2021-11-18
Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant App 20210290684 - Demopulos; Gregory A. ; et al.	2021-09-23
Antibodies Specifically Binding To Masp-3 For The Treatment Of Various Diseases And Disorders App 20210275667 - Cummings; W. Jason ; et al.	2021-09-09
Methods For Inhibiting Angiogenesis In A Subject In Need Thereof App 20210189009 - Demopulos; Gregory A. ; et al.	2021-06-24
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders Grant 11,027,015 - Cummings , et al. June 8, 2	2021-06-08
Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant Grant 11,013,772 - Demopulos , et al. May 25, 2	2021-05-25
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20210054098 - Demopulos; Gregory A. ; et al.	2021-02-25
Compositions For Inhibiting Masp-2 Dependent Complement Activation App 20210054099 - Dudler; Thomas ; et al.	2021-02-25
Methods for inhibiting angiogenesis in a subject in need thereof Grant 10,870,708 - Demopulos , et al. December 22, 2	2020-12-22
Antibodies Specifically Binding To Masp-3 For The Treatment Of Various Diseases And Disorders App 20200317510 - Cummings; W. Jason ; et al.	2020-10-08
Nucleic Acids Encoding Antibodies Specifically Binding To Masp-3 App 20200270125 - Cummings; W. Jason ; et al.	2020-08-27
Nucleic acids encoding antibodies specifically binding to MASP-3 Grant 10,745,274 - Cummings , et al. A	2020-08-18
Compositions for inhibiting MASP-2 dependent complement activation Grant 10,683,367 - Dudler , et al.	2020-06-16
Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation App 20200157245 - Schwaeble; Hans-Wilhelm ; et al.	2020-05-21
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20200157244 - Demopulos; Gregory A. ; et al.	2020-05-21
Compositions and Methods of Inhibiting MASP-2 for the Treatment of Various Thrombotic Diseases and Disorders App 20200140570 - Demopulos; Gregory A. ; et al.	2020-05-07
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders Grant 10,639,369 - Cummings , et al.	2020-05-05
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20200048366 - Demopulos; Gregory A. ; et al.	2020-02-13
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20190292272 - Demopulos; Gregory A. ; et al.	2019-09-26
Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant App 20190125802 - Demopulos; Gregory A. ; et al.	2019-05-02
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders App 20190127484 - Schwaeble; Hans-Wilhelm ; et al.	2019-05-02
Compositions for Inhibiting MASP-2 Dependent Complement Activation App 20190119402 - Dudler; Thomas ; et al.	2019-04-25
Methods for treating conditions associated with MASP-2 dependent complement activation Grant 10,202,465 - Demopulos , et al. Feb	2019-02-12
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20190016824 - Demopulos; Gregory A. ; et al.	2019-01-17
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation App 20180291112 - Schwaeble; Hans-Wilhelm ; et al.	2018-10-11
Methods for treating conditions associated with MASP-2 dependent complement activation Grant 10,059,776 - Demopulos , et al. August 28, 2	2018-08-28
Compositions for inhibiting MASP-2 dependent complement activation Grant 10,047,165 - Dudler , et al. August 14, 2	2018-08-14
Compositions and Methods of Inhibiting MASP-3 for the Treatment of Various Diseases and Disorders App 20180140697 - Cummings; W. Jason ; et al.	2018-05-24
Methods for Inhibiting Angiogenesis in a Subject in Need Thereof App 20170283508 - Demopulos; Gregory A. ; et al.	2017-10-05
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20170267781 - Demopulos; Gregory A. ; et al.	2017-09-21
Methods For Inhibiting Fibrosis In A Subject In Need Thereof App 20170253667 - Brunskill; Nigel John ; et al.	2017-09-07
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation App 20170233494 - Schwaeble; Hans-Wilhelm ; et al.	2017-08-17
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20170166659 - Demopulos; Gregory A. ; et al.	2017-06-15
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20170166658 - Demopulos; Gregory A. ; et al.	2017-06-15
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20170137537 - Demopulos; Gregory A. ; et al.	2017-05-18
Methods for treating conditions associated with MASP-2 dependent complement activation Grant 9,644,035 - Demopulos , et al. May 9, 2	2017-05-09
Compositions For Inhibiting Masp-2 Dependent Complement Activation App 20170088632 - Dudler; Thomas ; et al.	2017-03-30
Compositions for inhibiting MASP-2 dependent complement activation Grant 9,475,885 - Dudler , et al. October 25, 2	2016-10-25
Compositions For Inhibiting Masp-2 Dependent Complement Activation App 20160002349 - Dudler; Thomas ; et al.	2016-01-07
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20150239985 - Demopulos; Gregory A. ; et al.	2015-08-27
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20150166675 - Demopulos; Gregory A. ; et al.	2015-06-18
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20150166676 - Demopulos; Gregory A. ; et al.	2015-06-18
Compositions for inhibiting MASP-2 dependent complement activation Grant 9,011,860 - Dudler , et al. April 21, 2	2015-04-21
Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation App 20150064176 - Schwaeble; Hans-Wilhelm ; et al.	2015-03-05
Methods for treating conditions associated with MASP-2 dependent complement activation Grant 8,951,522 - Demopulos , et al. February 10, 2	2015-02-10
Methods for treating conditions associated with MASP-2 dependent complement activation Grant 8,840,893 - Schwaeble , et al. September 23, 2	2014-09-23
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation App 20140205598 - Schwaeble; Hans-Wilhelm ; et al.	2014-07-24
Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation Grant 8,652,477 - Schwaeble , et al. February 18, 2	2014-02-18
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders App 20130344073 - Schwaeble; Hans-Wilhelm ; et al.	2013-12-26
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20130266560 - Demopulos; Gregory A. ; et al.	2013-10-10
Compositions For Inhibiting Masp-2 Dependent Complement Activation App 20120282263 - Dudler; Thomas ; et al.	2012-11-08
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation App 20120258095 - Demopulos; Gregory A. ; et al.	2012-10-11
Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation App 20110311549 - Schwaeble; Hans-Wilhelm ; et al.	2011-12-22
Methods For Treating Disseminated Intravascular Coagulation By Inhibiting Masp-2 Dependent Complement Activation App 20110091450 - Schwaeble; Hans-Wilhelm ; et al.	2011-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.